|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ARTICLE |
in myocytes and brown adipocytes
1 Departamento de Bioquimica y Biologia Molecular II, Facultad de Farmacia, Universidad Complutense, 28040-Madrid, Spain
* To whom correspondence should be addressed. E-mail: mlorenzo{at}farm.ucm.es.
| Abstract |
|---|
Insulin resistance is an important contributor to the pathogenesis of type 2 diabetes and obesity is a risk factor for its development, due in part, to the fact that adipose tissue secretes proteins, called adipokines, that may influence insulin sensitivity. Among these molecules, tumor necrosis factor (TNF)-
has been proposed as a link between obesity and insulin resistance because TNF-
is overexpressed in adipose tissues of obese animals and humans, and obese mice lacking either TNF-
or its receptor show protection for developing insulin resistance. The direct exposure to TNF-
induced a state of insulin resistance on glucose uptake in myocytes and brown adipocytes, due to the activation of pro-inflammatory pathways that impair insulin-signaling at the level of the insulin receptor substrate (IRS) proteins. In this regard, the Ser307 residue in IRS-1 has been identified as a site for TNF-
-inhibitory effects in myotubes, with p38 mitogen-activated protein kinase (MAPK) and inhibitor kB kinase being involved in the phosphorylation of this residue. Conversely, serine phosphorylation of IRS-2 mediated by TNF-
activation of MAPK was the mechanism found in brown adipocytes. Protein-tyrosine phosphatase (PTP)1B acts as a physiological negative regulator of insulin signaling by dephosphorylating the phosphotyrosine residues of the insulin receptor and IRS-1, and PTP1B expression is increased in muscle and white adipose tissue of obese and diabetic humans and rodents. Moreover, up-regulation of PTP1B expression was recently found in cells treated with TNF-
. Accordingly, myocytes and primary brown adipocytes deficient on PTP1B are protected against insulin resistance induced by this cytokine. Furthermore, down-regulation of PTP1B activity is also possible by the use of pharmacological agonists of nuclear receptors that restored insulin sensitivity in the presence of TNF-
. In conclusion, the lack of PTP1B in muscle and brown adipocytes increase insulin sensitivity and glucose uptake and could confer protection against insulin resistance induced by adipokines.
Key Words: glucose uptake, liver X receptor, protein-tyrosine phosphatase 1B, obesity, p38 mitogen-activated protein kinase, rosiglitazone
This article has been cited by other articles:
![]() |
I. K.M. Law, A. Xu, K. S.L. Lam, T. Berger, T. W. Mak, P. M. Vanhoutte, J. T.C. Liu, G. Sweeney, M. Zhou, B. Yang, et al. Lipocalin-2 Deficiency Attenuates Insulin Resistance Associated With Aging and Obesity Diabetes, April 1, 2010; 59(4): 872 - 882. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chung, M. Kim, B.-S. Youn, N. S. Lee, J. W. Park, I. K. Lee, Y. S. Lee, J. B. Kim, Y. M. Cho, H. K. Lee, et al. Glutathione Peroxidase 3 Mediates the Antioxidant Effect of Peroxisome Proliferator-Activated Receptor {gamma} in Human Skeletal Muscle Cells Mol. Cell. Biol., January 1, 2009; 29(1): 20 - 30. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |